Due for re-check: the scheduled review date of 2026-09-04 has passed. Every value below still carries the source it was taken from and the passage that states it — check it against the link.
25021-115-02 · Clindamycin Phosphate Injection · Sagent Pharmaceuticals
What is the package ndc for 25021-115-02 · Clindamycin Phosphate Injection · Sagent Pharmaceuticals?
For 25021-115-02 · Clindamycin Phosphate Injection · Sagent Pharmaceuticals, package ndc is 25021-115-02; generic name is Clindamycin Phosphate Injection; manufacturer is Sagent Pharmaceuticals; status is Current; availability now is Limited Availability, recorded from its source on 2026-09-01.
"initial_posting_date": "03/21/2023", "package_ndc": "25021-115-02", "generic_name": "Clindamycin Phosphate Injection", "contact_info": "866-625-1618", "availability": "Limited Availability", "related_info": "Selling through remaining short-dated inventory (Dec 2026), API not available, Exiting product line"
— api.fda.gov, retrieved 2026-09-01
- Package NDC
- 25021-115-02 verified
- Generic name
- Clindamycin Phosphate Injection verified
- Manufacturer
- Sagent Pharmaceuticals verified
- Status
- Current verified
- Availability now
- Limited Availability verified
- FDA note
- Selling through remaining short-dated inventory (Dec 2026), API not available, Exiting product line verified
- Initial posting date
- 03/21/2023 verified
- Last update date
- 08/18/2026 verified
- Days in shortage
- 1260 our reading
- Reason for shortage
- Discontinuation of the manufacture of the drug verified
- Dosage form
- Injection verified
- Therapeutic category
- Anti-Infective verified
Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Manufacturer, Status, Last update date, Reason for shortage, Dosage form and Therapeutic category
"update_date": "08/18/2026", "therapeutic_category": [ "Anti-Infective" ], "dosage_form": "Injection", "presentation": "Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-02)", "company_name": "Sagent Pharmaceuticals", "shortage_reason": "Discontinuation of the manufacture of the drug", "status": "Current"
— all from api.fda.gov, retrieved 2026-09-01
Source
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sagent%20Pharmaceuticals%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000